{
  "doc_id": "22",
  "paragraphs": [
    {
      "paragraph_id": "0",
      "paragraph": "《基于肠促胰素的药物治疗临床应用的快速建议指南》",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "《基于肠促胰素的药物治疗临床应用的快速建议指南》",
          "start_idx": 0,
          "end_idx": 24,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "1",
      "paragraph": "肠促胰素(incretin)是一种经食物刺激后由肠细胞分泌入血、能够刺激胰岛素分泌的激素。基于肠促胰素的治疗药物(incretin-based therapies，IBTs)通过与器官上的特异性受体结合，发挥类肠促胰素作用，从而达到降糖疗效。由于这类药物具有低血糖风险小和改善细胞功能等多方面的优势，逐渐在临床广泛使用。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "肠促胰素(incretin)是一种经食物刺激后由肠细胞分泌入血、能够刺激胰岛素分泌的激素。",
          "start_idx": 0,
          "end_idx": 45,
          "entities": [],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": "基于肠促胰素的治疗药物(incretin-based therapies，IBTs)通过与器官上的特异性受体结合，发挥类肠促胰素作用，从而达到降糖疗效。",
          "start_idx": 45,
          "end_idx": 121,
          "entities": [],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "由于这类药物具有低血糖风险小和改善细胞功能等多方面的优势，逐渐在临床广泛使用。",
          "start_idx": 121,
          "end_idx": 160,
          "entities": [
            {
              "entity_id": "T0",
              "entity": "低血糖",
              "entity_type": "ADE",
              "start_idx": 8,
              "end_idx": 11
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "2",
      "paragraph": "目前在国内已经上市了两种胰高血糖素样肽-1受体激动剂(Glucagon-likepeptide-1 receptoragonists，GLP-1RA)：包括艾塞那肽(Exenatide和利拉鲁肽(Liraglutide)，以及5种二肽基肽酶Ⅳ抑制剂(Dipeptidyl Peptidase- 4 inhibitor，DPP-4i)：包括西格列汀(Sitagliptin)、维格列汀(Vildagliptin)、沙格列汀(Saxagliptin)、利格列汀(Linagliptin)和阿格列汀(Alogliptin)(表1)",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "目前在国内已经上市了两种胰高血糖素样肽-1受体激动剂(Glucagon-likepeptide-1 receptoragonists，GLP-1RA)：包括艾塞那肽(Exenatide和利拉鲁肽(Liraglutide)，以及5种二肽基肽酶Ⅳ抑制剂(Dipeptidyl Peptidase- 4 inhibitor，DPP-4i)：包括西格列汀(Sitagliptin)、维格列汀(Vildagliptin)、沙格列汀(Saxagliptin)、利格列汀(Linagliptin)和阿格列汀(Alogliptin)(表1)",
          "start_idx": 0,
          "end_idx": 262,
          "entities": [
            {
              "entity_id": "T1",
              "entity": "胰高血糖素样肽-1受体激动剂(Glucagon-likepeptide-1 receptoragonists，GLP-1RA)",
              "entity_type": "Drug",
              "start_idx": 12,
              "end_idx": 75
            },
            {
              "entity_id": "T2",
              "entity": "艾塞那肽(Exenatide",
              "entity_type": "Drug",
              "start_idx": 78,
              "end_idx": 92
            },
            {
              "entity_id": "T3",
              "entity": "利拉鲁肽(Liraglutide)",
              "entity_type": "Drug",
              "start_idx": 93,
              "end_idx": 110
            },
            {
              "entity_id": "T4",
              "entity": "二肽基肽酶Ⅳ抑制剂(Dipeptidyl Peptidase- 4 inhibitor，DPP-4i)",
              "entity_type": "Drug",
              "start_idx": 115,
              "end_idx": 166
            },
            {
              "entity_id": "T5",
              "entity": "西格列汀(Sitagliptin)",
              "entity_type": "Drug",
              "start_idx": 169,
              "end_idx": 186
            },
            {
              "entity_id": "T6",
              "entity": "维格列汀(Vildagliptin)",
              "entity_type": "Drug",
              "start_idx": 187,
              "end_idx": 205
            },
            {
              "entity_id": "T7",
              "entity": "沙格列汀(Saxagliptin)",
              "entity_type": "Drug",
              "start_idx": 206,
              "end_idx": 223
            },
            {
              "entity_id": "T8",
              "entity": "利格列汀(Linagliptin)",
              "entity_type": "Drug",
              "start_idx": 224,
              "end_idx": 241
            },
            {
              "entity_id": "T9",
              "entity": "阿格列汀(Alogliptin)",
              "entity_type": "Drug",
              "start_idx": 242,
              "end_idx": 258
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "3",
      "paragraph": "基于肠促胰素的治疗药物的出现为临床医生提供了更多选择，但它们的有效性、安全性和经济性究竟如何?基于肠促胰素的治疗药物在特殊人群(如老年患者)中使用有哪些注意事项?特别是这类药物在全球临床指南中地位变化迅速时，我们该如何评价、选择和应用?这些问题都有待于采用系统、科学的方法来回答。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "基于肠促胰素的治疗药物的出现为临床医生提供了更多选择，但它们的有效性、安全性和经济性究竟如何?基于肠促胰素的治疗药物在特殊人群(如老年患者)中使用有哪些注意事项?特别是这类药物在全球临床指南中地位变化迅速时，我们该如何评价、选择和应用?这些问题都有待于采用系统、科学的方法来回答。",
          "start_idx": 0,
          "end_idx": 140,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "4",
      "paragraph": "本指南采用GRADE(the Grading of Recommendation Assessment，Development and Evaluation)证据质量评价与推荐强度系统。证据量评价：A表示高质量，B表示中等质量，C表示低质量，D表示极低质量；推荐强度：1表示强推荐，2表示弱推荐，0表示无明确推荐意见。(见表2、3)",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "本指南采用GRADE(the Grading of Recommendation Assessment，Development and Evaluation)证据质量评价与推荐强度系统。",
          "start_idx": 0,
          "end_idx": 93,
          "entities": [],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": "证据量评价：A表示高质量，B表示中等质量，C表示低质量，D表示极低质量；推荐强度：1表示强推荐，2表示弱推荐，0表示无明确推荐意见。",
          "start_idx": 93,
          "end_idx": 159,
          "entities": [],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "(见表2、3)",
          "start_idx": 159,
          "end_idx": 166,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "5",
      "paragraph": "临床问题1：DPP-4i是否可作为2型糖尿病患者的一线治疗选择之一?",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床问题1：DPP-4i是否可作为2型糖尿病患者的一线治疗选择之一?",
          "start_idx": 0,
          "end_idx": 34,
          "entities": [
            {
              "entity_id": "T10",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 12
            },
            {
              "entity_id": "T11",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 17,
              "end_idx": 22
            },
            {
              "entity_id": "T12",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 17,
              "end_idx": 19
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R0",
              "head_entity_id": "T10",
              "tail_entity_id": "T11"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R1",
              "head_entity_id": "T12",
              "tail_entity_id": "T11"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "6",
      "paragraph": "推荐意见 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐意见 ",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "7",
      "paragraph": "推荐D PP-4i作为2型糖尿病患者的一线治疗选择之一。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐D PP-4i作为2型糖尿病患者的一线治疗选择之一。",
          "start_idx": 0,
          "end_idx": 28,
          "entities": [
            {
              "entity_id": "T13",
              "entity": "D PP-4i",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 9
            },
            {
              "entity_id": "T14",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 11,
              "end_idx": 16
            },
            {
              "entity_id": "T15",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 11,
              "end_idx": 13
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R2",
              "head_entity_id": "T13",
              "tail_entity_id": "T14"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R3",
              "head_entity_id": "T15",
              "tail_entity_id": "T14"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "8",
      "paragraph": "推荐说明",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐说明",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "9",
      "paragraph": "二甲双胍被各国指南推荐作为2型糖尿病患者的一线治疗药物。在二甲双胍不耐受或存在使用禁忌等情况下，DPP-4i可以作为一线的替代治疗药物。DPP-4i的推荐剂量为说明书中规定的常规使用剂量。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "二甲双胍被各国指南推荐作为2型糖尿病患者的一线治疗药物。",
          "start_idx": 0,
          "end_idx": 28,
          "entities": [
            {
              "entity_id": "T16",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 4
            },
            {
              "entity_id": "T17",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 13,
              "end_idx": 18
            },
            {
              "entity_id": "T18",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 13,
              "end_idx": 15
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R4",
              "head_entity_id": "T16",
              "tail_entity_id": "T17"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R5",
              "head_entity_id": "T18",
              "tail_entity_id": "T17"
            }
          ]
        },
        {
          "sentence_id": "1",
          "sentence": "在二甲双胍不耐受或存在使用禁忌等情况下，DPP-4i可以作为一线的替代治疗药物。",
          "start_idx": 28,
          "end_idx": 68,
          "entities": [
            {
              "entity_id": "T19",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 1,
              "end_idx": 5
            },
            {
              "entity_id": "T20",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 20,
              "end_idx": 26
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "2",
          "sentence": "DPP-4i的推荐剂量为说明书中规定的常规使用剂量。",
          "start_idx": 68,
          "end_idx": 94,
          "entities": [
            {
              "entity_id": "T21",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 6
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "10",
      "paragraph": "推荐等级：1 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐等级：1 ",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "11",
      "paragraph": "证据级别：B",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "证据级别：B",
          "start_idx": 0,
          "end_idx": 6,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "12",
      "paragraph": "临床问题2：在单药治疗血糖控制不佳情况下，DPP-4i是否可作为2型糖尿病患者的二线治疗选择之一? ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床问题2：在单药治疗血糖控制不佳情况下，DPP-4i是否可作为2型糖尿病患者的二线治疗选择之一? ",
          "start_idx": 0,
          "end_idx": 50,
          "entities": [
            {
              "entity_id": "T22",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 11,
              "end_idx": 13
            },
            {
              "entity_id": "T23",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 21,
              "end_idx": 27
            },
            {
              "entity_id": "T24",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 32,
              "end_idx": 37
            },
            {
              "entity_id": "T25",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 32,
              "end_idx": 34
            },
            {
              "entity_id": "T26",
              "entity": "控制不佳",
              "entity_type": "Test_Value",
              "start_idx": 13,
              "end_idx": 17
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R6",
              "head_entity_id": "T22",
              "tail_entity_id": "T24"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R7",
              "head_entity_id": "T23",
              "tail_entity_id": "T24"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R8",
              "head_entity_id": "T25",
              "tail_entity_id": "T24"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "13",
      "paragraph": "推荐意见 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐意见 ",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "14",
      "paragraph": "推荐DPP-4i作为2型糖尿病患者的二线治疗之一。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐DPP-4i作为2型糖尿病患者的二线治疗之一。",
          "start_idx": 0,
          "end_idx": 25,
          "entities": [
            {
              "entity_id": "T27",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 8
            },
            {
              "entity_id": "T28",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 10,
              "end_idx": 15
            },
            {
              "entity_id": "T29",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 10,
              "end_idx": 12
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R9",
              "head_entity_id": "T27",
              "tail_entity_id": "T28"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R10",
              "head_entity_id": "T29",
              "tail_entity_id": "T28"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "15",
      "paragraph": "推荐说明 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐说明 ",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "16",
      "paragraph": "当二甲双胍或者其他降糖药物单药治疗后，糖化血红蛋白水平仍未达标，则需联合另外一种降糖药治疗。推荐等级：1 证据级别：B",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "当二甲双胍或者其他降糖药物单药治疗后，糖化血红蛋白水平仍未达标，则需联合另外一种降糖药治疗。",
          "start_idx": 0,
          "end_idx": 46,
          "entities": [
            {
              "entity_id": "T30",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 1,
              "end_idx": 5
            },
            {
              "entity_id": "T31",
              "entity": "糖化血红蛋白",
              "entity_type": "Test_items",
              "start_idx": 19,
              "end_idx": 25
            },
            {
              "entity_id": "T32",
              "entity": "未达标",
              "entity_type": "Test_Value",
              "start_idx": 28,
              "end_idx": 31
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": "推荐等级：1 证据级别：B",
          "start_idx": 46,
          "end_idx": 59,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "17",
      "paragraph": "临床问题3：在二线治疗控制不佳情况下，DPP-4i是否可作为2型糖尿病患者的三线治疗",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床问题3：在二线治疗控制不佳情况下，DPP-4i是否可作为2型糖尿病患者的三线治疗",
          "start_idx": 0,
          "end_idx": 42,
          "entities": [
            {
              "entity_id": "T33",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 19,
              "end_idx": 25
            },
            {
              "entity_id": "T34",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 30,
              "end_idx": 35
            },
            {
              "entity_id": "T35",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 30,
              "end_idx": 32
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R11",
              "head_entity_id": "T33",
              "tail_entity_id": "T34"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R12",
              "head_entity_id": "T35",
              "tail_entity_id": "T34"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "18",
      "paragraph": "选择之一?",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "选择之一?",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "19",
      "paragraph": "推荐意见推荐DPP-4i作为2型糖尿病患者的三线治疗选择之一。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐意见推荐DPP-4i作为2型糖尿病患者的三线治疗选择之一。",
          "start_idx": 0,
          "end_idx": 31,
          "entities": [
            {
              "entity_id": "T36",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 12
            },
            {
              "entity_id": "T37",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 14,
              "end_idx": 19
            },
            {
              "entity_id": "T38",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 14,
              "end_idx": 16
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R13",
              "head_entity_id": "T36",
              "tail_entity_id": "T37"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R14",
              "head_entity_id": "T38",
              "tail_entity_id": "T37"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "20",
      "paragraph": "推荐说明 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐说明 ",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "21",
      "paragraph": "由于DPP-4i具有较好的有效性和安全性，在二线治疗时仍未使用DPP-4i治疗的患者，推荐DPP-4i作为2型糖尿病患者的三线治疗选择之一。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "由于DPP-4i具有较好的有效性和安全性，在二线治疗时仍未使用DPP-4i治疗的患者，推荐DPP-4i作为2型糖尿病患者的三线治疗选择之一。",
          "start_idx": 0,
          "end_idx": 70,
          "entities": [
            {
              "entity_id": "T39",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 8
            },
            {
              "entity_id": "T40",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 31,
              "end_idx": 37
            },
            {
              "entity_id": "T41",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 45,
              "end_idx": 51
            },
            {
              "entity_id": "T42",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 53,
              "end_idx": 58
            },
            {
              "entity_id": "T43",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 53,
              "end_idx": 55
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R15",
              "head_entity_id": "T41",
              "tail_entity_id": "T42"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R16",
              "head_entity_id": "T43",
              "tail_entity_id": "T42"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "22",
      "paragraph": "推荐等级：1 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐等级：1 ",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "23",
      "paragraph": "证据级别：B",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "证据级别：B",
          "start_idx": 0,
          "end_idx": 6,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "24",
      "paragraph": "临床问题4：DPP-4i联合基础胰岛素是否可用于2型糖尿病患者的降糖治疗?",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床问题4：DPP-4i联合基础胰岛素是否可用于2型糖尿病患者的降糖治疗?",
          "start_idx": 0,
          "end_idx": 37,
          "entities": [
            {
              "entity_id": "T44",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 12
            },
            {
              "entity_id": "T45",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 16,
              "end_idx": 19
            },
            {
              "entity_id": "T46",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 24,
              "end_idx": 29
            },
            {
              "entity_id": "T47",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 24,
              "end_idx": 26
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R17",
              "head_entity_id": "T44",
              "tail_entity_id": "T46"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R18",
              "head_entity_id": "T45",
              "tail_entity_id": "T46"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R19",
              "head_entity_id": "T47",
              "tail_entity_id": "T46"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "25",
      "paragraph": "推荐意见 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐意见 ",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "26",
      "paragraph": "推荐DPP-4i联合基础胰岛素用于2型糖尿病的降糖治疗。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐DPP-4i联合基础胰岛素用于2型糖尿病的降糖治疗。",
          "start_idx": 0,
          "end_idx": 28,
          "entities": [
            {
              "entity_id": "T48",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 8
            },
            {
              "entity_id": "T49",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 12,
              "end_idx": 15
            },
            {
              "entity_id": "T50",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 17,
              "end_idx": 22
            },
            {
              "entity_id": "T51",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 17,
              "end_idx": 19
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R20",
              "head_entity_id": "T48",
              "tail_entity_id": "T50"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R21",
              "head_entity_id": "T49",
              "tail_entity_id": "T50"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "27",
      "paragraph": "推荐说明 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐说明 ",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "28",
      "paragraph": "当使用基础胰岛素进行治疗，糖化血红蛋白控制不佳时，可添加DPP-4i进行联合治疗，并根据糖化血红蛋白水平，调整胰岛素的剂量。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "当使用基础胰岛素进行治疗，糖化血红蛋白控制不佳时，可添加DPP-4i进行联合治疗，并根据糖化血红蛋白水平，调整胰岛素的剂量。",
          "start_idx": 0,
          "end_idx": 62,
          "entities": [
            {
              "entity_id": "T52",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 5,
              "end_idx": 8
            },
            {
              "entity_id": "T53",
              "entity": "糖化血红蛋白",
              "entity_type": "Test_items",
              "start_idx": 13,
              "end_idx": 19
            },
            {
              "entity_id": "T54",
              "entity": "控制不佳",
              "entity_type": "Test_Value",
              "start_idx": 19,
              "end_idx": 23
            },
            {
              "entity_id": "T55",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 28,
              "end_idx": 34
            },
            {
              "entity_id": "T56",
              "entity": "糖化血红蛋白",
              "entity_type": "Test_items",
              "start_idx": 44,
              "end_idx": 50
            },
            {
              "entity_id": "T57",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 55,
              "end_idx": 58
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "29",
      "paragraph": "推荐等级：1 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐等级：1 ",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "30",
      "paragraph": " 证据级别：B",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": " 证据级别：B",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "31",
      "paragraph": "临床问题5：DPP-4i是否可用于65岁以上的2型糖尿病患者的降糖治疗? ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床问题5：DPP-4i是否可用于65岁以上的2型糖尿病患者的降糖治疗? ",
          "start_idx": 0,
          "end_idx": 37,
          "entities": [
            {
              "entity_id": "T58",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 12
            },
            {
              "entity_id": "T59",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 23,
              "end_idx": 28
            },
            {
              "entity_id": "T60",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 23,
              "end_idx": 25
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R22",
              "head_entity_id": "T58",
              "tail_entity_id": "T59"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R23",
              "head_entity_id": "T60",
              "tail_entity_id": "T59"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "32",
      "paragraph": "推荐意见",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐意见",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "33",
      "paragraph": "推荐DPP-4i用于65岁以上的2型糖尿病患者糖治疗。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐DPP-4i用于65岁以上的2型糖尿病患者糖治疗。",
          "start_idx": 0,
          "end_idx": 27,
          "entities": [
            {
              "entity_id": "T61",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 8
            },
            {
              "entity_id": "T62",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 16,
              "end_idx": 21
            },
            {
              "entity_id": "T63",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 16,
              "end_idx": 18
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R24",
              "head_entity_id": "T61",
              "tail_entity_id": "T62"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R25",
              "head_entity_id": "T63",
              "tail_entity_id": "T62"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "34",
      "paragraph": "推荐说明",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐说明",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "35",
      "paragraph": "由于老年患者常常合并多种并发疾病，DPP-4i具有良好的血糖控制效果和安全性，推荐DPP-4i用于老年2型糖尿病患者的降糖治疗。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "由于老年患者常常合并多种并发疾病，DPP-4i具有良好的血糖控制效果和安全性，推荐DPP-4i用于老年2型糖尿病患者的降糖治疗。",
          "start_idx": 0,
          "end_idx": 64,
          "entities": [
            {
              "entity_id": "T64",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 17,
              "end_idx": 23
            },
            {
              "entity_id": "T65",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 28,
              "end_idx": 30
            },
            {
              "entity_id": "T66",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 41,
              "end_idx": 47
            },
            {
              "entity_id": "T67",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 51,
              "end_idx": 56
            },
            {
              "entity_id": "T68",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 51,
              "end_idx": 53
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R26",
              "head_entity_id": "T65",
              "tail_entity_id": "T67"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R27",
              "head_entity_id": "T66",
              "tail_entity_id": "T67"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R28",
              "head_entity_id": "T68",
              "tail_entity_id": "T67"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "36",
      "paragraph": "推荐使用常规剂量进行治疗，除非伴有肝或肾功能不全，需根据说明书进行剂量调整。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐使用常规剂量进行治疗，除非伴有肝或肾功能不全，需根据说明书进行剂量调整。",
          "start_idx": 0,
          "end_idx": 38,
          "entities": [
            {
              "entity_id": "T69",
              "entity": "肝或肾功能不全",
              "entity_type": "Disease",
              "start_idx": 17,
              "end_idx": 24
            },
            {
              "entity_id": "T70",
              "entity": "肝",
              "entity_type": "Anatomy",
              "start_idx": 17,
              "end_idx": 18
            },
            {
              "entity_id": "T71",
              "entity": "肾",
              "entity_type": "Anatomy",
              "start_idx": 19,
              "end_idx": 20
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R29",
              "head_entity_id": "T70",
              "tail_entity_id": "T69"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R30",
              "head_entity_id": "T71",
              "tail_entity_id": "T69"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "37",
      "paragraph": "推荐等级：1 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐等级：1 ",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "38",
      "paragraph": "证据级别：B",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "证据级别：B",
          "start_idx": 0,
          "end_idx": 6,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "39",
      "paragraph": "临床问题6：DPP-4i是否可用于超重/肥胖2型糖尿病患者的降糖治疗? ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床问题6：DPP-4i是否可用于超重/肥胖2型糖尿病患者的降糖治疗? ",
          "start_idx": 0,
          "end_idx": 36,
          "entities": [
            {
              "entity_id": "T72",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 12
            },
            {
              "entity_id": "T73",
              "entity": "超重",
              "entity_type": "Disease",
              "start_idx": 17,
              "end_idx": 19
            },
            {
              "entity_id": "T74",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 20,
              "end_idx": 22
            },
            {
              "entity_id": "T75",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 22,
              "end_idx": 27
            },
            {
              "entity_id": "T76",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 22,
              "end_idx": 24
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R31",
              "head_entity_id": "T72",
              "tail_entity_id": "T75"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R32",
              "head_entity_id": "T76",
              "tail_entity_id": "T75"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "40",
      "paragraph": "推荐意见DPP-4i可用于超重/肥胖2型糖尿病患者的降疗。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐意见DPP-4i可用于超重/肥胖2型糖尿病患者的降疗。",
          "start_idx": 0,
          "end_idx": 29,
          "entities": [
            {
              "entity_id": "T77",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 4,
              "end_idx": 10
            },
            {
              "entity_id": "T78",
              "entity": "超重",
              "entity_type": "Disease",
              "start_idx": 13,
              "end_idx": 15
            },
            {
              "entity_id": "T79",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 16,
              "end_idx": 18
            },
            {
              "entity_id": "T80",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 18,
              "end_idx": 23
            },
            {
              "entity_id": "T81",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 18,
              "end_idx": 20
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R33",
              "head_entity_id": "T77",
              "tail_entity_id": "T80"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R34",
              "head_entity_id": "T81",
              "tail_entity_id": "T80"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "41",
      "paragraph": "推荐说明",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐说明",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "42",
      "paragraph": "由于DPP-4i不影响患者的体重，故建议DPP-4i用于超重/肥胖2型糖尿病患者的降糖治疗。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "由于DPP-4i不影响患者的体重，故建议DPP-4i用于超重/肥胖2型糖尿病患者的降糖治疗。",
          "start_idx": 0,
          "end_idx": 46,
          "entities": [
            {
              "entity_id": "T82",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 8
            },
            {
              "entity_id": "T83",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 20,
              "end_idx": 26
            },
            {
              "entity_id": "T84",
              "entity": "超重",
              "entity_type": "Disease",
              "start_idx": 28,
              "end_idx": 30
            },
            {
              "entity_id": "T85",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 31,
              "end_idx": 33
            },
            {
              "entity_id": "T86",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 33,
              "end_idx": 38
            },
            {
              "entity_id": "T87",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 33,
              "end_idx": 35
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R35",
              "head_entity_id": "T83",
              "tail_entity_id": "T86"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R36",
              "head_entity_id": "T87",
              "tail_entity_id": "T86"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "43",
      "paragraph": "推荐等级：2 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐等级：2 ",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "44",
      "paragraph": "证据级别：C",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "证据级别：C",
          "start_idx": 0,
          "end_idx": 6,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "45",
      "paragraph": "临床问题7：DPP-4i是否可用于伴有心血管疾病或心血管事件风险的2型糖尿病患者的降糖治疗? 推荐意见",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床问题7：DPP-4i是否可用于伴有心血管疾病或心血管事件风险的2型糖尿病患者的降糖治疗? 推荐意见",
          "start_idx": 0,
          "end_idx": 51,
          "entities": [
            {
              "entity_id": "T88",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 12
            },
            {
              "entity_id": "T89",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 33,
              "end_idx": 38
            },
            {
              "entity_id": "T90",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 33,
              "end_idx": 35
            },
            {
              "entity_id": "T91",
              "entity": "心血管疾病",
              "entity_type": "Disease",
              "start_idx": 19,
              "end_idx": 24
            },
            {
              "entity_id": "T92",
              "entity": "心血管事件",
              "entity_type": "Disease",
              "start_idx": 25,
              "end_idx": 30
            },
            {
              "entity_id": "T93",
              "entity": "心血管",
              "entity_type": "Anatomy",
              "start_idx": 19,
              "end_idx": 22
            },
            {
              "entity_id": "T94",
              "entity": "心血管",
              "entity_type": "Anatomy",
              "start_idx": 25,
              "end_idx": 28
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R37",
              "head_entity_id": "T88",
              "tail_entity_id": "T89"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R38",
              "head_entity_id": "T90",
              "tail_entity_id": "T89"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R39",
              "head_entity_id": "T93",
              "tail_entity_id": "T91"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R40",
              "head_entity_id": "T94",
              "tail_entity_id": "T92"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "46",
      "paragraph": "DPP-4i可用于伴有心血管疾病或心血管事件的2型糖尿病患者的降糖治疗。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "DPP-4i可用于伴有心血管疾病或心血管事件的2型糖尿病患者的降糖治疗。",
          "start_idx": 0,
          "end_idx": 36,
          "entities": [
            {
              "entity_id": "T95",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 6
            },
            {
              "entity_id": "T96",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 23,
              "end_idx": 28
            },
            {
              "entity_id": "T97",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 23,
              "end_idx": 25
            },
            {
              "entity_id": "T98",
              "entity": "心血管疾病",
              "entity_type": "Disease",
              "start_idx": 11,
              "end_idx": 16
            },
            {
              "entity_id": "T99",
              "entity": "心血管",
              "entity_type": "Anatomy",
              "start_idx": 11,
              "end_idx": 14
            },
            {
              "entity_id": "T100",
              "entity": "心血管事件",
              "entity_type": "Disease",
              "start_idx": 17,
              "end_idx": 22
            },
            {
              "entity_id": "T101",
              "entity": "心血管",
              "entity_type": "Anatomy",
              "start_idx": 17,
              "end_idx": 20
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R41",
              "head_entity_id": "T95",
              "tail_entity_id": "T96"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R42",
              "head_entity_id": "T97",
              "tail_entity_id": "T96"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R43",
              "head_entity_id": "T99",
              "tail_entity_id": "T98"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R44",
              "head_entity_id": "T101",
              "tail_entity_id": "T100"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "47",
      "paragraph": "推荐说明 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐说明 ",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "48",
      "paragraph": "基于证据总结和专家意见，DPP-4i可用于血管疾病或心血管事件风险的2型糖尿病患者。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "基于证据总结和专家意见，DPP-4i可用于血管疾病或心血管事件风险的2型糖尿病患者。",
          "start_idx": 0,
          "end_idx": 42,
          "entities": [
            {
              "entity_id": "T102",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 12,
              "end_idx": 18
            },
            {
              "entity_id": "T103",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 34,
              "end_idx": 39
            },
            {
              "entity_id": "T104",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 34,
              "end_idx": 36
            },
            {
              "entity_id": "T105",
              "entity": "血管疾病",
              "entity_type": "Disease",
              "start_idx": 21,
              "end_idx": 25
            },
            {
              "entity_id": "T106",
              "entity": "血管",
              "entity_type": "Anatomy",
              "start_idx": 21,
              "end_idx": 23
            },
            {
              "entity_id": "T107",
              "entity": "心血管事件",
              "entity_type": "Disease",
              "start_idx": 26,
              "end_idx": 31
            },
            {
              "entity_id": "T108",
              "entity": "心血管",
              "entity_type": "Anatomy",
              "start_idx": 26,
              "end_idx": 29
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R45",
              "head_entity_id": "T102",
              "tail_entity_id": "T103"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R46",
              "head_entity_id": "T104",
              "tail_entity_id": "T103"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R47",
              "head_entity_id": "T106",
              "tail_entity_id": "T105"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R48",
              "head_entity_id": "T108",
              "tail_entity_id": "T107"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "49",
      "paragraph": "推荐等级：2 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐等级：2 ",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "50",
      "paragraph": "证据级别：B",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "证据级别：B",
          "start_idx": 0,
          "end_idx": 6,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "51",
      "paragraph": "临床问题8：复方制剂(DPP-4i和二甲双胍)是否可用于2型糖尿病患者的起始降糖治疗? ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床问题8：复方制剂(DPP-4i和二甲双胍)是否可用于2型糖尿病患者的起始降糖治疗? ",
          "start_idx": 0,
          "end_idx": 44,
          "entities": [
            {
              "entity_id": "T109",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 11,
              "end_idx": 17
            },
            {
              "entity_id": "T110",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 18,
              "end_idx": 22
            },
            {
              "entity_id": "T111",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 28,
              "end_idx": 33
            },
            {
              "entity_id": "T112",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 28,
              "end_idx": 30
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R49",
              "head_entity_id": "T109",
              "tail_entity_id": "T111"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R50",
              "head_entity_id": "T110",
              "tail_entity_id": "T111"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R51",
              "head_entity_id": "T112",
              "tail_entity_id": "T111"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "52",
      "paragraph": "推荐意见",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐意见",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "53",
      "paragraph": "推荐复方制剂(DPP-4i和二甲双胍)用于2型糖病患者的起始降糖治疗。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐复方制剂(DPP-4i和二甲双胍)用于2型糖病患者的起始降糖治疗。",
          "start_idx": 0,
          "end_idx": 35,
          "entities": [
            {
              "entity_id": "T113",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 7,
              "end_idx": 13
            },
            {
              "entity_id": "T114",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 14,
              "end_idx": 18
            },
            {
              "entity_id": "T115",
              "entity": "2型糖病",
              "entity_type": "Disease",
              "start_idx": 21,
              "end_idx": 25
            },
            {
              "entity_id": "T116",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 21,
              "end_idx": 23
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R52",
              "head_entity_id": "T113",
              "tail_entity_id": "T115"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R53",
              "head_entity_id": "T114",
              "tail_entity_id": "T115"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R54",
              "head_entity_id": "T116",
              "tail_entity_id": "T115"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "54",
      "paragraph": "推荐说明",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐说明",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "55",
      "paragraph": "对于HbA1c>7.5%的首次治疗患者，推荐使用复方制剂(DPP-4i和二甲双胍)进行起始治疗。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "对于HbA1c>7.5%的首次治疗患者，推荐使用复方制剂(DPP-4i和二甲双胍)进行起始治疗。",
          "start_idx": 0,
          "end_idx": 48,
          "entities": [
            {
              "entity_id": "T117",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 2,
              "end_idx": 7
            },
            {
              "entity_id": "T118",
              "entity": ">7.5%",
              "entity_type": "Test_Value",
              "start_idx": 7,
              "end_idx": 12
            },
            {
              "entity_id": "T119",
              "entity": "DPP-4i",
              "entity_type": "Drug",
              "start_idx": 29,
              "end_idx": 35
            },
            {
              "entity_id": "T120",
              "entity": "二甲双胍",
              "entity_type": "Drug",
              "start_idx": 36,
              "end_idx": 40
            }
          ],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "56",
      "paragraph": "推荐等级：1 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐等级：1 ",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "57",
      "paragraph": "证据级别：B",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "证据级别：B",
          "start_idx": 0,
          "end_idx": 6,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "58",
      "paragraph": "临床问题9：在单药治疗血糖控制不佳情况下，GLP-1RA是否可作为2型糖尿病患者的二线治疗选择之一? ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床问题9：在单药治疗血糖控制不佳情况下，GLP-1RA是否可作为2型糖尿病患者的二线治疗选择之一? ",
          "start_idx": 0,
          "end_idx": 51,
          "entities": [
            {
              "entity_id": "T121",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 11,
              "end_idx": 13
            },
            {
              "entity_id": "T122",
              "entity": "控制不佳",
              "entity_type": "Test_Value",
              "start_idx": 13,
              "end_idx": 17
            },
            {
              "entity_id": "T123",
              "entity": "GLP-1RA",
              "entity_type": "Drug",
              "start_idx": 21,
              "end_idx": 28
            },
            {
              "entity_id": "T124",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 33,
              "end_idx": 38
            },
            {
              "entity_id": "T125",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 33,
              "end_idx": 35
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R55",
              "head_entity_id": "T121",
              "tail_entity_id": "T124"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R56",
              "head_entity_id": "T123",
              "tail_entity_id": "T124"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R57",
              "head_entity_id": "T125",
              "tail_entity_id": "T124"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "59",
      "paragraph": "推荐意见 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐意见 ",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "60",
      "paragraph": "推荐GLP—1RA作为2型糖尿病患者的二线治疗择之一。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐GLP—1RA作为2型糖尿病患者的二线治疗择之一。",
          "start_idx": 0,
          "end_idx": 27,
          "entities": [
            {
              "entity_id": "T126",
              "entity": "GLP—1RA",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 9
            },
            {
              "entity_id": "T127",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 11,
              "end_idx": 16
            },
            {
              "entity_id": "T128",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 11,
              "end_idx": 13
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R58",
              "head_entity_id": "T126",
              "tail_entity_id": "T127"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R59",
              "head_entity_id": "T128",
              "tail_entity_id": "T127"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "61",
      "paragraph": "推荐说明 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐说明 ",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "62",
      "paragraph": "由于GLP一1RA具有较好控制血糖和降低体重的作用，在单药治疗血糖控制不佳的情况，推荐GLP—1RA作为2型糖尿病患者的治疗选择。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "由于GLP一1RA具有较好控制血糖和降低体重的作用，在单药治疗血糖控制不佳的情况，推荐GLP—1RA作为2型糖尿病患者的治疗选择。",
          "start_idx": 0,
          "end_idx": 65,
          "entities": [
            {
              "entity_id": "T129",
              "entity": "GLP一1RA",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 9
            },
            {
              "entity_id": "T130",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 15,
              "end_idx": 17
            },
            {
              "entity_id": "T131",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 31,
              "end_idx": 33
            },
            {
              "entity_id": "T132",
              "entity": "控制不佳",
              "entity_type": "Test_Value",
              "start_idx": 33,
              "end_idx": 37
            },
            {
              "entity_id": "T133",
              "entity": "GLP—1RA",
              "entity_type": "Drug",
              "start_idx": 43,
              "end_idx": 50
            },
            {
              "entity_id": "T134",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 52,
              "end_idx": 57
            },
            {
              "entity_id": "T135",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 52,
              "end_idx": 54
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R60",
              "head_entity_id": "T131",
              "tail_entity_id": "T134"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R61",
              "head_entity_id": "T133",
              "tail_entity_id": "T134"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R62",
              "head_entity_id": "T135",
              "tail_entity_id": "T134"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "63",
      "paragraph": "推荐等级：1 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐等级：1 ",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "64",
      "paragraph": "证据级别：B",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "证据级别：B",
          "start_idx": 0,
          "end_idx": 6,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "65",
      "paragraph": "临床问题10：在二线治疗控制不佳情况下，GLP-1RA是否可作为2型糖尿病患者的三线治疗选择之一?",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床问题10：在二线治疗控制不佳情况下，GLP-1RA是否可作为2型糖尿病患者的三线治疗选择之一?",
          "start_idx": 0,
          "end_idx": 49,
          "entities": [
            {
              "entity_id": "T136",
              "entity": "GLP-1RA",
              "entity_type": "Drug",
              "start_idx": 20,
              "end_idx": 27
            },
            {
              "entity_id": "T137",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 32,
              "end_idx": 37
            },
            {
              "entity_id": "T138",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 32,
              "end_idx": 34
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R63",
              "head_entity_id": "T136",
              "tail_entity_id": "T137"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R64",
              "head_entity_id": "T138",
              "tail_entity_id": "T137"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "66",
      "paragraph": "推荐意见",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐意见",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "67",
      "paragraph": "推荐GLP一1RA作为2型糖尿病患者的三线治疗选择之一。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐GLP一1RA作为2型糖尿病患者的三线治疗选择之一。",
          "start_idx": 0,
          "end_idx": 28,
          "entities": [
            {
              "entity_id": "T139",
              "entity": "GLP一1RA",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 9
            },
            {
              "entity_id": "T140",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 11,
              "end_idx": 16
            },
            {
              "entity_id": "T141",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 11,
              "end_idx": 13
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R65",
              "head_entity_id": "T139",
              "tail_entity_id": "T140"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R66",
              "head_entity_id": "T141",
              "tail_entity_id": "T140"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "68",
      "paragraph": "推荐说明",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐说明",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "69",
      "paragraph": "由于GLP—1RA具有较好的血糖控制效果，在二线治疗时血糖仍控制不佳的患者，推荐GLP-1RA作为2型糖尿病患者的三线治疗选择之一。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "由于GLP—1RA具有较好的血糖控制效果，在二线治疗时血糖仍控制不佳的患者，推荐GLP-1RA作为2型糖尿病患者的三线治疗选择之一。",
          "start_idx": 0,
          "end_idx": 66,
          "entities": [
            {
              "entity_id": "T142",
              "entity": "GLP—1RA",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 9
            },
            {
              "entity_id": "T143",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 14,
              "end_idx": 16
            },
            {
              "entity_id": "T144",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 27,
              "end_idx": 29
            },
            {
              "entity_id": "T145",
              "entity": "控制不佳",
              "entity_type": "Test_Value",
              "start_idx": 30,
              "end_idx": 34
            },
            {
              "entity_id": "T146",
              "entity": "GLP-1RA",
              "entity_type": "Drug",
              "start_idx": 40,
              "end_idx": 47
            },
            {
              "entity_id": "T147",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 49,
              "end_idx": 54
            },
            {
              "entity_id": "T148",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 49,
              "end_idx": 51
            }
          ],
          "relations": [
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R67",
              "head_entity_id": "T144",
              "tail_entity_id": "T147"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R68",
              "head_entity_id": "T146",
              "tail_entity_id": "T147"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R69",
              "head_entity_id": "T148",
              "tail_entity_id": "T147"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "70",
      "paragraph": "推荐等级：1 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐等级：1 ",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "71",
      "paragraph": "证据级别：B",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "证据级别：B",
          "start_idx": 0,
          "end_idx": 6,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "72",
      "paragraph": "临床问题11：GLP-1RA联合基础胰岛素是否可用于2型糖尿病患者的降糖治疗?",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床问题11：GLP-1RA联合基础胰岛素是否可用于2型糖尿病患者的降糖治疗?",
          "start_idx": 0,
          "end_idx": 39,
          "entities": [
            {
              "entity_id": "T149",
              "entity": "GLP-1RA",
              "entity_type": "Drug",
              "start_idx": 7,
              "end_idx": 14
            },
            {
              "entity_id": "T150",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 18,
              "end_idx": 21
            },
            {
              "entity_id": "T151",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 26,
              "end_idx": 31
            },
            {
              "entity_id": "T152",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 26,
              "end_idx": 28
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R70",
              "head_entity_id": "T149",
              "tail_entity_id": "T151"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R71",
              "head_entity_id": "T150",
              "tail_entity_id": "T151"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R72",
              "head_entity_id": "T152",
              "tail_entity_id": "T151"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "73",
      "paragraph": "推荐意见推荐GLP一1RA联合基础胰岛素用于2型糖尿病患者的降糖治疗。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐意见推荐GLP一1RA联合基础胰岛素用于2型糖尿病患者的降糖治疗。",
          "start_idx": 0,
          "end_idx": 35,
          "entities": [
            {
              "entity_id": "T153",
              "entity": "GLP一1RA",
              "entity_type": "Drug",
              "start_idx": 6,
              "end_idx": 13
            },
            {
              "entity_id": "T154",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 17,
              "end_idx": 20
            },
            {
              "entity_id": "T155",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 22,
              "end_idx": 27
            },
            {
              "entity_id": "T156",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 22,
              "end_idx": 24
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R73",
              "head_entity_id": "T153",
              "tail_entity_id": "T155"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R74",
              "head_entity_id": "T154",
              "tail_entity_id": "T155"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R75",
              "head_entity_id": "T156",
              "tail_entity_id": "T155"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "74",
      "paragraph": "推荐说明",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐说明",
          "start_idx": 0,
          "end_idx": 4,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "75",
      "paragraph": "当使用基础胰岛素进行治疗，糖化血红蛋白水平仍控制不佳时，可添GLP-1RA进行联合治疗并根据糖化血红蛋白水平，调整胰岛素的剂量。推荐等级：1",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "当使用基础胰岛素进行治疗，糖化血红蛋白水平仍控制不佳时，可添GLP-1RA进行联合治疗并根据糖化血红蛋白水平，调整胰岛素的剂量。",
          "start_idx": 0,
          "end_idx": 64,
          "entities": [
            {
              "entity_id": "T157",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 5,
              "end_idx": 8
            },
            {
              "entity_id": "T158",
              "entity": "糖化血红蛋白",
              "entity_type": "Test_items",
              "start_idx": 13,
              "end_idx": 19
            },
            {
              "entity_id": "T159",
              "entity": "控制不佳",
              "entity_type": "Test_Value",
              "start_idx": 22,
              "end_idx": 26
            },
            {
              "entity_id": "T160",
              "entity": "GLP-1RA",
              "entity_type": "Drug",
              "start_idx": 30,
              "end_idx": 37
            },
            {
              "entity_id": "T161",
              "entity": "糖化血红蛋白",
              "entity_type": "Test_items",
              "start_idx": 46,
              "end_idx": 52
            },
            {
              "entity_id": "T162",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 57,
              "end_idx": 60
            }
          ],
          "relations": []
        },
        {
          "sentence_id": "1",
          "sentence": "推荐等级：1",
          "start_idx": 64,
          "end_idx": 70,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "76",
      "paragraph": "证据级别：B",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "证据级别：B",
          "start_idx": 0,
          "end_idx": 6,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "77",
      "paragraph": "临床问题12：GLP-1RA是否可用于超重/肥胖2型糖尿病患者的降糖治疗? ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床问题12：GLP-1RA是否可用于超重/肥胖2型糖尿病患者的降糖治疗? ",
          "start_idx": 0,
          "end_idx": 38,
          "entities": [
            {
              "entity_id": "T163",
              "entity": "GLP-1RA",
              "entity_type": "Drug",
              "start_idx": 7,
              "end_idx": 14
            },
            {
              "entity_id": "T164",
              "entity": "超重",
              "entity_type": "Disease",
              "start_idx": 19,
              "end_idx": 21
            },
            {
              "entity_id": "T165",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 22,
              "end_idx": 24
            },
            {
              "entity_id": "T166",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 24,
              "end_idx": 29
            },
            {
              "entity_id": "T167",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 24,
              "end_idx": 26
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R76",
              "head_entity_id": "T163",
              "tail_entity_id": "T166"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R77",
              "head_entity_id": "T167",
              "tail_entity_id": "T166"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "78",
      "paragraph": "推荐意见 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐意见 ",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "79",
      "paragraph": "建议GLP-1RA用于超重/fie胖2型糖尿病患者的降糖治疗。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "建议GLP-1RA用于超重/fie胖2型糖尿病患者的降糖治疗。",
          "start_idx": 0,
          "end_idx": 31,
          "entities": [
            {
              "entity_id": "T168",
              "entity": "GLP-1RA",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 9
            },
            {
              "entity_id": "T169",
              "entity": "超重",
              "entity_type": "Disease",
              "start_idx": 11,
              "end_idx": 13
            },
            {
              "entity_id": "T170",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 18,
              "end_idx": 23
            },
            {
              "entity_id": "T171",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 18,
              "end_idx": 20
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R78",
              "head_entity_id": "T168",
              "tail_entity_id": "T170"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R79",
              "head_entity_id": "T171",
              "tail_entity_id": "T170"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "80",
      "paragraph": "推荐说明 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐说明 ",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "81",
      "paragraph": "由于GLP-1RA可显著降低患者体重，对于超重/肥胖的2型糖尿病患者，建议GLP-1RA用于超重/肥胖患者的降糖治疗。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "由于GLP-1RA可显著降低患者体重，对于超重/肥胖的2型糖尿病患者，建议GLP-1RA用于超重/肥胖患者的降糖治疗。",
          "start_idx": 0,
          "end_idx": 59,
          "entities": [
            {
              "entity_id": "T172",
              "entity": "GLP-1RA",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 9
            },
            {
              "entity_id": "T173",
              "entity": "超重",
              "entity_type": "Disease",
              "start_idx": 21,
              "end_idx": 23
            },
            {
              "entity_id": "T174",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 24,
              "end_idx": 26
            },
            {
              "entity_id": "T175",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 27,
              "end_idx": 32
            },
            {
              "entity_id": "T176",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 27,
              "end_idx": 29
            },
            {
              "entity_id": "T177",
              "entity": "GLP-1RA",
              "entity_type": "Drug",
              "start_idx": 37,
              "end_idx": 44
            },
            {
              "entity_id": "T178",
              "entity": "超重",
              "entity_type": "Disease",
              "start_idx": 46,
              "end_idx": 48
            },
            {
              "entity_id": "T179",
              "entity": "肥胖",
              "entity_type": "Disease",
              "start_idx": 49,
              "end_idx": 51
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R80",
              "head_entity_id": "T172",
              "tail_entity_id": "T175"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R81",
              "head_entity_id": "T176",
              "tail_entity_id": "T175"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "82",
      "paragraph": "推荐等级：2 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐等级：2 ",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "83",
      "paragraph": "证据级别：B",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "证据级别：B",
          "start_idx": 0,
          "end_idx": 6,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "84",
      "paragraph": "临床问题13：GLP-1RA是否可用于伴有非酒精性脂肪肝的2型糖尿病患者的降糖治疗? ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "临床问题13：GLP-1RA是否可用于伴有非酒精性脂肪肝的2型糖尿病患者的降糖治疗? ",
          "start_idx": 0,
          "end_idx": 43,
          "entities": [
            {
              "entity_id": "T180",
              "entity": "GLP-1RA",
              "entity_type": "Drug",
              "start_idx": 7,
              "end_idx": 14
            },
            {
              "entity_id": "T181",
              "entity": "非酒精性脂肪肝",
              "entity_type": "Disease",
              "start_idx": 21,
              "end_idx": 28
            },
            {
              "entity_id": "T182",
              "entity": "肝",
              "entity_type": "Anatomy",
              "start_idx": 27,
              "end_idx": 28
            },
            {
              "entity_id": "T183",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 29,
              "end_idx": 34
            },
            {
              "entity_id": "T184",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 29,
              "end_idx": 31
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R82",
              "head_entity_id": "T180",
              "tail_entity_id": "T183"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R83",
              "head_entity_id": "T182",
              "tail_entity_id": "T181"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R84",
              "head_entity_id": "T184",
              "tail_entity_id": "T183"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "85",
      "paragraph": "推荐意见 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐意见 ",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "86",
      "paragraph": "建议GLP-1RA用于伴有非酒精性脂肪肝2型糖尿病患者的降糖治疗。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "建议GLP-1RA用于伴有非酒精性脂肪肝2型糖尿病患者的降糖治疗。",
          "start_idx": 0,
          "end_idx": 33,
          "entities": [
            {
              "entity_id": "T185",
              "entity": "GLP-1RA",
              "entity_type": "Drug",
              "start_idx": 2,
              "end_idx": 9
            },
            {
              "entity_id": "T186",
              "entity": "非酒精性脂肪肝",
              "entity_type": "Disease",
              "start_idx": 13,
              "end_idx": 20
            },
            {
              "entity_id": "T187",
              "entity": "肝",
              "entity_type": "Anatomy",
              "start_idx": 19,
              "end_idx": 20
            },
            {
              "entity_id": "T188",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 20,
              "end_idx": 25
            },
            {
              "entity_id": "T189",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 20,
              "end_idx": 22
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R85",
              "head_entity_id": "T185",
              "tail_entity_id": "T188"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R86",
              "head_entity_id": "T187",
              "tail_entity_id": "T186"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R87",
              "head_entity_id": "T189",
              "tail_entity_id": "T188"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "87",
      "paragraph": "推荐说明 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐说明 ",
          "start_idx": 0,
          "end_idx": 5,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "88",
      "paragraph": "对于伴有非酒精性脂肪肝的2型糖尿病患者GLP-1RA可降低BMI和ALT水平，建议使用GLP-1RA进行治疗。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "对于伴有非酒精性脂肪肝的2型糖尿病患者GLP-1RA可降低BMI和ALT水平，建议使用GLP-1RA进行治疗。",
          "start_idx": 0,
          "end_idx": 55,
          "entities": [
            {
              "entity_id": "T190",
              "entity": "非酒精性脂肪肝",
              "entity_type": "Disease",
              "start_idx": 4,
              "end_idx": 11
            },
            {
              "entity_id": "T191",
              "entity": "肝",
              "entity_type": "Anatomy",
              "start_idx": 10,
              "end_idx": 11
            },
            {
              "entity_id": "T192",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 12,
              "end_idx": 17
            },
            {
              "entity_id": "T193",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 12,
              "end_idx": 14
            },
            {
              "entity_id": "T194",
              "entity": "GLP-1RA",
              "entity_type": "Drug",
              "start_idx": 19,
              "end_idx": 26
            },
            {
              "entity_id": "T195",
              "entity": "ALT",
              "entity_type": "Test_items",
              "start_idx": 33,
              "end_idx": 36
            },
            {
              "entity_id": "T196",
              "entity": "GLP-1RA",
              "entity_type": "Drug",
              "start_idx": 43,
              "end_idx": 50
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R88",
              "head_entity_id": "T191",
              "tail_entity_id": "T190"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R89",
              "head_entity_id": "T193",
              "tail_entity_id": "T192"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R90",
              "head_entity_id": "T194",
              "tail_entity_id": "T192"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R91",
              "head_entity_id": "T195",
              "tail_entity_id": "T192"
            }
          ]
        }
      ]
    },
    {
      "paragraph_id": "89",
      "paragraph": "推荐等级：2 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "推荐等级：2 ",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": []
        }
      ]
    },
    {
      "paragraph_id": "90",
      "paragraph": "证据级别：C",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "证据级别：C",
          "start_idx": 0,
          "end_idx": 6,
          "entities": [],
          "relations": []
        }
      ]
    }
  ]
}